V.I.P.S. Medical SA : Plasma and Cryo Viro- Inactivation is not a nice to have for worldwide patients

Non-virally inactivated plasma, cryoprecipitate , produce locally, are still used in many countries in the world, in both the developing world and industrialized countries,

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) December 5, 2011 --Non-virally inactivated plasma, cryoprecipitate , produce locally, are still used in many countries in the world, in both the developing world and industrialized countries, for the treatment of various hematological, trauma or surgery blood disorders. In the absence of viral inactivation treatment, , the exposure for transmission of plasma-borne viruses, most critically HIV and Hepatitis B (HBV) or C (HCV), emerging viruses such as Hepatitis delta West Nile , Dengue Shikungunya, SARS or Malaria, Leis mania, Chagas, Babesiosis . V.I.P.S. SA have adapted the well-established industrial solvent–detergent (SD) viral inactivation treatment to allow its application in a small scale using a single-use plastic bag system. The procedure can be used by Local, Regional blood establishments, without the need to build an industrial-scale manufacturing facility. Results show a good recovery of the functional activity of plasma proteins, including coagulation factors (such as factor VIII and coagulable fibrinogen) and/or protease inhibitors (such as alpha 2-antiplasmin). Viral validation studies revealed reduction factors greater than 4.17, greater than 4.73 and greater than 4.72 for HIV, BVDV and PRV, respectively, within a few minutes of treatment. A single-use SD treatment and SD-elimination system is currently ready to ship to allow standardized use of the procedure by blood establishments or national or regional service centers. These Medical Devices were announced by V.I.P.S. SA CEO Valerie Soulié during the International ISBT Congress Lisboa 2011 . “ VIPS Cryo and VIPS Plasma are in production, on time delivery is one of the goals of the company and this ISO metric is part of our management score card. We are deploying our S/D technology in volume and will continue to focus, country by country, in making it happening” , V.I.P.S. SA next challenge is in Turkey and we will be present during the National blood Congress in Antalya next week..

More information can be found online at http://www.vipsmedical.com

blood     cryoprecipitate     Gerard Lopez     hbc     hbv     hiv     plasma